Singapore Institute of Advanced Medicine Holdings Ltd. stock analysis
Want to see SG:9G2 full AI Analyst Report?
Singapore Institute of Advanced Medicine Holdings Ltd. (9G2) Share Price & Analysis
9G2 Stock Chart & Stats
- Day’s Range
- SGD 0.02 - SGD 0.02
- 52-Week Range
- SGD 0.02 - SGD 0.08
- Previous Close
- SGD 0.02
- Volume
- N/A
- Average Volume (3M)
- 1.32M
- Market Cap
- SGD 41.38M
- Enterprise Value
- SGD 100.16M
- Total Cash (Recent Filing)
- SGD 7.24M
- Total Debt (Recent Filing)
- SGD 59.12M
- Price to Earnings (P/E)
- ―
- Beta
- -0.14
- Next Earnings
- Feb 12, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Strong Gross Margin
A gross margin near 92% indicates attractive underlying economics in the company’s specialist healthcare services. If management can control overhead and restore revenue growth, this substantial gross-profit base could provide operating leverage and support a path toward improved profitability.
Improved Leverage
The reduction in leverage from earlier years strengthens financial flexibility relative to the company’s prior position. Positive equity also provides some balance-sheet support, potentially allowing management more time to improve operations, although current leverage remains meaningful.
Narrower Operating Cash Burn
The narrowing operating cash outflow suggests some progress in containing the cash cost of running the business. Continued improvement could reduce reliance on external funding and make the company’s specialist-care platform more resilient while it works toward breakeven.
Bears Say
Material Revenue Decline
The sharp 2026 revenue contraction weakens operating leverage and makes the company’s high fixed-cost burden harder to absorb. Unless revenue stabilizes, the decline can prolong losses, reduce funding capacity, and undermine the ability to scale specialist healthcare operations.
Persistent Deep Losses
Losses remain extremely large relative to revenue, showing that gross profit is currently overwhelmed by overhead and other costs. Persistent unprofitability limits internal funding, depresses returns on equity, and leaves the business dependent on a credible turnaround in cost structure.
Ongoing Negative Cash Generation
Consistently negative operating and free cash flow means the business continues to consume cash rather than fund itself. Even with some improvement in operating burn, sustained outflows increase funding risk and can constrain investment in clinical services and future growth.
Singapore Institute of Advanced Medicine Holdings Ltd. News
Singapore Institute of Advanced Medicine Clarifies Interim Financial Statements
Singapore Institute of Advanced Medicine Holdings Ltd. ( ($SG:9G2) ) has provided an update. Singapore Institute of Advanced Medicine Holdings issued a clarification to its unaudited condensed interim consolidated financial
Singapore Institute of Advanced Medicine revamps board, races to restore committee compliance
Singapore Institute of Advanced Medicine Holdings Ltd. ( ($SG:9G2) ) has provided an update. Singapore Institute of Advanced Medicine Holdings Ltd. has announced changes to its board and board committees,
Singapore Institute of Advanced Medicine Details Use of S$14.94 Million Rights Issue Proceeds
Singapore Institute of Advanced Medicine Holdings Ltd. ( ($SG:9G2) ) has provided an announcement. Singapore Institute of Advanced Medicine Holdings Ltd. has detailed how it is deploying net proceeds of
Singapore Institute of Advanced Medicine Details Use of S$14.9m Rights Issue Proceeds
Singapore Institute of Advanced Medicine Holdings Ltd. ( ($SG:9G2) ) has issued an announcement. Singapore Institute of Advanced Medicine Holdings Ltd. has provided an update on the deployment of approximately
Singapore Institute of Advanced Medicine Expands Capital Base with Rights and Warrants Issue
The latest update is out from Singapore Institute of Advanced Medicine Holdings Ltd. ( ($SG:9G2) ). Singapore Institute of Advanced Medicine Holdings has completed a renounceable non-underwritten rights-cum-warrants issue, allotting
Singapore Institute of Advanced Medicine Raises S$14.94 Million in Oversubscribed Rights-Cum-Warrants Issue
Singapore Institute of Advanced Medicine Holdings Ltd. ( ($SG:9G2) ) has issued an announcement. Singapore Institute of Advanced Medicine Holdings has successfully completed a renounceable non-underwritten rights-cum-warrants issue that was
9G2 FAQ
What was Singapore Institute of Advanced Medicine Holdings Ltd.’s price range in the past 12 months?
What is Singapore Institute of Advanced Medicine Holdings Ltd.’s market cap?
When is Singapore Institute of Advanced Medicine Holdings Ltd.’s upcoming earnings report date?
How were Singapore Institute of Advanced Medicine Holdings Ltd.’s earnings last quarter?
Is Singapore Institute of Advanced Medicine Holdings Ltd. overvalued?
Does Singapore Institute of Advanced Medicine Holdings Ltd. pay dividends?
What is Singapore Institute of Advanced Medicine Holdings Ltd.’s EPS estimate?
How many shares outstanding does Singapore Institute of Advanced Medicine Holdings Ltd. have?
What happened to Singapore Institute of Advanced Medicine Holdings Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Singapore Institute of Advanced Medicine Holdings Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Singapore Institute of Advanced Medicine Holdings Ltd. Stock Smart Score
Company Description
Singapore Institute of Advanced Medicine Holdings Ltd.
Singapore Institute of Advanced Medicine Holdings Ltd. operates as a holding company primarily focused on delivering healthcare services. Its operations include providing pharmaceutical products, surgical supplies, and medical laboratory services. The company was founded by Djeng Shih Kien on November 24, 2011, and is headquartered in Singapore.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Shih Kien Djeng
- Employees
- 104
- Website
- www.advancedmedicine.sg
- Address
- No. 02-01, 1 Biopolis Drive, Singapore, CE, 138622, SG
Singapore Institute of Advanced Medicine Holdings Ltd. (9G2) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 1 | 6 | 14 |
| Technical Analysis | 1 | 6 | 2 |
| Moving Averages | 0 | 0 | 12 |








